nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Eructation—Doxorubicin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Ceftibuten—Melaena—Doxorubicin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Ceftibuten—Agitation—Vincristine—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Ceftibuten—Candida infection—Doxorubicin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Ceftibuten—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Ceftibuten—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Ceftibuten—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Ceftibuten—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Ceftibuten—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Ceftibuten—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Ceftibuten—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Ceftibuten—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Ceftibuten—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Ceftibuten—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Ceftibuten—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Ceftibuten—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Ceftibuten—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Ceftibuten—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Ceftibuten—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Ceftibuten—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Ceftibuten—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Ceftibuten—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Ceftibuten—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Ceftibuten—Chills—Etoposide—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Ceftibuten—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Ceftibuten—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Ceftibuten—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Ceftibuten—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Ceftibuten—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Ceftibuten—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Ceftibuten—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Ceftibuten—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Ceftibuten—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Ceftibuten—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Ceftibuten—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Ceftibuten—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Ceftibuten—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Ceftibuten—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Ceftibuten—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Ceftibuten—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Ceftibuten—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Ceftibuten—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Ceftibuten—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Ceftibuten—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Ceftibuten—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Ceftibuten—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Ceftibuten—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Ceftibuten—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Ceftibuten—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Ceftibuten—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Ceftibuten—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Ceftibuten—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Ceftibuten—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Ceftibuten—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Ceftibuten—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Ceftibuten—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Ceftibuten—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Ceftibuten—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Ceftibuten—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Ceftibuten—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Ceftibuten—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Ceftibuten—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Ceftibuten—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Ceftibuten—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Ceftibuten—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Ceftibuten—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Ceftibuten—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Ceftibuten—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Ceftibuten—Rash—Topotecan—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Ceftibuten—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Ceftibuten—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Ceftibuten—Headache—Topotecan—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Ceftibuten—Rash—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Ceftibuten—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Ceftibuten—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Ceftibuten—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Ceftibuten—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Ceftibuten—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Ceftibuten—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Ceftibuten—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Ceftibuten—Headache—Tretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Ceftibuten—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Ceftibuten—Constipation—Vincristine—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Ceftibuten—Rash—Melphalan—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Ceftibuten—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Ceftibuten—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Ceftibuten—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Ceftibuten—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Ceftibuten—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Ceftibuten—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Ceftibuten—Nausea—Topotecan—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Ceftibuten—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Ceftibuten—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Ceftibuten—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Ceftibuten—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Ceftibuten—Nausea—Melphalan—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Ceftibuten—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Ceftibuten—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Ceftibuten—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Ceftibuten—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Ceftibuten—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Ceftibuten—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Ceftibuten—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Ceftibuten—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Ceftibuten—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Ceftibuten—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Ceftibuten—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Ceftibuten—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Ceftibuten—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Ceftibuten—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Ceftibuten—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Ceftibuten—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Ceftibuten—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Ceftibuten—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Ceftibuten—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Ceftibuten—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Ceftibuten—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Ceftibuten—Rash—Dactinomycin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Ceftibuten—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Ceftibuten—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Ceftibuten—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Ceftibuten—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Ceftibuten—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Ceftibuten—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Ceftibuten—Constipation—Etoposide—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Ceftibuten—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Ceftibuten—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Ceftibuten—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Ceftibuten—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Ceftibuten—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Ceftibuten—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Ceftibuten—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Ceftibuten—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Ceftibuten—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Ceftibuten—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Ceftibuten—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Ceftibuten—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Ceftibuten—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Ceftibuten—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Ceftibuten—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Ceftibuten—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Ceftibuten—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Ceftibuten—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Ceftibuten—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Ceftibuten—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Ceftibuten—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Ceftibuten—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Ceftibuten—Rash—Vincristine—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Ceftibuten—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Ceftibuten—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Ceftibuten—Headache—Vincristine—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Ceftibuten—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Ceftibuten—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Ceftibuten—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Ceftibuten—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Ceftibuten—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Ceftibuten—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Ceftibuten—Nausea—Vincristine—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Ceftibuten—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Ceftibuten—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Ceftibuten—Chills—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Ceftibuten—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Ceftibuten—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Ceftibuten—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Ceftibuten—Rash—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Ceftibuten—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Ceftibuten—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Ceftibuten—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Ceftibuten—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Ceftibuten—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Ceftibuten—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Ceftibuten—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Ceftibuten—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Ceftibuten—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Ceftibuten—Rash—Etoposide—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Ceftibuten—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Ceftibuten—Headache—Etoposide—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Ceftibuten—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Ceftibuten—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Ceftibuten—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Ceftibuten—Nausea—Etoposide—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Ceftibuten—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Ceftibuten—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000987	0.000987	CcSEcCtD
Ceftibuten—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000968	0.000968	CcSEcCtD
Ceftibuten—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Ceftibuten—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000923	0.000923	CcSEcCtD
Ceftibuten—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000914	0.000914	CcSEcCtD
Ceftibuten—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Ceftibuten—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000875	0.000875	CcSEcCtD
Ceftibuten—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000869	0.000869	CcSEcCtD
Ceftibuten—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000863	0.000863	CcSEcCtD
Ceftibuten—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00086	0.00086	CcSEcCtD
Ceftibuten—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.000854	CcSEcCtD
Ceftibuten—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000852	0.000852	CcSEcCtD
Ceftibuten—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000841	0.000841	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000836	0.000836	CcSEcCtD
Ceftibuten—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000834	0.000834	CcSEcCtD
Ceftibuten—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000828	0.000828	CcSEcCtD
Ceftibuten—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00081	0.00081	CcSEcCtD
Ceftibuten—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000804	0.000804	CcSEcCtD
Ceftibuten—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000798	0.000798	CcSEcCtD
Ceftibuten—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000791	0.000791	CcSEcCtD
Ceftibuten—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000788	0.000788	CcSEcCtD
Ceftibuten—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000779	0.000779	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000773	0.000773	CcSEcCtD
Ceftibuten—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000772	0.000772	CcSEcCtD
Ceftibuten—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000769	0.000769	CcSEcCtD
Ceftibuten—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000766	0.000766	CcSEcCtD
Ceftibuten—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Ceftibuten—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000732	0.000732	CcSEcCtD
Ceftibuten—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000713	0.000713	CcSEcCtD
Ceftibuten—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.000711	CcSEcCtD
Ceftibuten—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000708	CcSEcCtD
Ceftibuten—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000708	CcSEcCtD
Ceftibuten—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000694	0.000694	CcSEcCtD
Ceftibuten—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Ceftibuten—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000662	0.000662	CcSEcCtD
Ceftibuten—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00066	0.00066	CcSEcCtD
Ceftibuten—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
Ceftibuten—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00064	0.00064	CcSEcCtD
Ceftibuten—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000634	0.000634	CcSEcCtD
Ceftibuten—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000615	0.000615	CcSEcCtD
Ceftibuten—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Ceftibuten—Rash—Epirubicin—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Ceftibuten—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Ceftibuten—Headache—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Ceftibuten—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.000592	CcSEcCtD
Ceftibuten—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Ceftibuten—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000569	0.000569	CcSEcCtD
Ceftibuten—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.000565	CcSEcCtD
Ceftibuten—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Ceftibuten—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000561	CcSEcCtD
Ceftibuten—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
